Evidence Partners, an Ottawa, ON-based provider of AI-enabled literature review automation software, raised $20M in Growth funding.
The round was led by Thomvest Ventures with participation from Pender Ventures and Export Development Canada.
The company intends to use the funds to accelerate global growth and hire additional product, engineering, sales, marketing, and customer success talent.
Led by CEO Peter O’Blenis, Evidence Partners provides DistillerSR™, an AI-enabled literature review automation software platform for research organizations to securely produce transparent, audit-ready and regulatory compliant literature reviews.
Today, more than 300 of the world’s leading research organizations, including more than 60 per cent of the largest pharmaceutical and medical device companies, use DistillerSR
FinSMEs
10/08/2022